This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.
New marketing authorisations
Table 1 shows the new marketing authorisations for July 2025
|
New Marketing Authorisations
|
|
Product name and target species
|
Active substance
|
Authorisation Holder, territory, and distribution category
|
Therapeutic group
|
|
Food Animals
|
|
BioEquin F Suspension for Injection for Horses
|
Equine influenza virus
|
Bioveta, a.s.
POM-V, NI
|
Inactivated Viral Vaccine
|
|
BioEquin FT Suspension for Injection for Horses
|
Clostridium tetani, Equine influenza virus
|
Bioveta, a.s.
POM-V, NI
|
Inactivated Viral and Bacterial Vaccine
|
|
Sulfequine 333 mg/g + 67 mg/g Oral Paste for Horses
|
Sulfadiazine, Trimethoprim
|
CP Pharma Handelsgesellschaft mbH
POM-V, NI
|
Antimicrobial
|
|
Ventimaxx 25 Microgram/ml Oral Solution for Horses
|
Clenbuterol hydrochloride
|
Alfasan Nederland B.V.
POM-V, NI
|
Respiratory expectorant
|
|
VeteCorH 1000 IU/ml Lyophilisate and Solvent for Solution for Injection for Cattle, Horses, Sheep, Goats, Pigs, Cats and Dogs
|
Chorionic Gonadotrophin
|
Laboratorios Calier, S.A.
POM-V, NI
|
Sex hormone
|
Changes to authorisations most relevant to vets
The changes to authorisations most relevant to vets can be found below. Each product is listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics (SPC) sections have been revised/changed.
Changes to the SPC, labels and leaflets may change how the medicines should be used. Details can be found on the VMD’s Product Information Database (PID) here.
Due to ongoing assessments, there may be a delay between the point at which a new change is authorised and the updated SPC being available on the PID. There may also be a delay between the point at which any SPC changes are authorised and implementation in the product literature. Unless you have been advised otherwise, the labelling instructions on the pack which is dispensed should be followed.
Food producing animals
Vey Tosal 100 mg/ml + 0.05 mg/ml Solution for Injection for Horses, Cattle and Dogs
Veyx-Pharma GmbH NI POM-V
Section 3.1: Removal of cats as a target species.
Section 3.2: updated indications:
All target species:
- Supportive treatment and prevention of hypophosphatemia and/or cyanocobalamin (vitamin B12) deficiency.
Horses:
- Adjunctive therapy in horses suffering from muscular exhaustion.
For more information, contact the VMD at postmaster@vmd.gov.uk